ArticleEpilepsia open2025

Real-world effectiveness and tolerability of cenobamate in drug-resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom.

Sylvain Rheims et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.